WallStSmart

CTS Corporation (CTS)vsZepp Health Corp (ZEPP)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

CTS Corporation generates 109% more annual revenue ($541.32M vs $258.90M). CTS leads profitability with a 12.1% profit margin vs -15.5%. CTS earns a higher WallStSmart Score of 65/100 (B-).

CTS

Strong Buy

65

out of 100

Grade: B-

Growth: 6.0Profit: 6.5Value: 4.7Quality: 5.0

ZEPP

Hold

41

out of 100

Grade: D

Growth: 4.7Profit: 2.0Value: 6.7Quality: 5.0
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

CTSSignificantly Overvalued (-75.0%)

Margin of Safety

-75.0%

Fair Value

$32.65

Current Price

$57.10

$24.45 premium

UndervaluedFair: $32.65Overvalued
ZEPPUndervalued (+48.6%)

Margin of Safety

+48.6%

Fair Value

$46.70

Current Price

$17.47

$29.23 discount

UndervaluedFair: $46.70Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

CTS1 strengths · Avg: 10.0/10
EPS GrowthGrowth
76.3%10/10

Earnings expanding 76.3% YoY

ZEPP2 strengths · Avg: 10.0/10
Price/BookValuation
1.3x10/10

Reasonable price relative to book value

Revenue GrowthGrowth
43.0%10/10

Revenue surging 43.0% year-over-year

Areas to Watch

CTS1 concerns · Avg: 3.0/10
Market CapQuality
$1.56B3/10

Smaller company, higher risk/reward

ZEPP4 concerns · Avg: 2.0/10
Market CapQuality
$247.54M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-17.2%2/10

ROE of -17.2% — below average capital efficiency

EPS GrowthGrowth
-68.1%2/10

Earnings declined 68.1%

Profit MarginProfitability
-15.5%1/10

Currently unprofitable

Comparative Analysis Report

WallStSmart Research

Bull Case : CTS

The strongest argument for CTS centers on EPS Growth. PEG of 1.41 suggests the stock is reasonably priced for its growth.

Bull Case : ZEPP

The strongest argument for ZEPP centers on Price/Book, Revenue Growth. Revenue growth of 43.0% demonstrates continued momentum.

Bear Case : CTS

The primary concerns for CTS are Market Cap.

Bear Case : ZEPP

The primary concerns for ZEPP are Market Cap, Return on Equity, EPS Growth.

Key Dynamics to Monitor

CTS profiles as a value stock while ZEPP is a hypergrowth play — different risk/reward profiles.

ZEPP carries more volatility with a beta of 1.77 — expect wider price swings.

ZEPP is growing revenue faster at 43.0% — sustainability is the question.

Monitor ELECTRONIC COMPONENTS industry trends, competitive dynamics, and regulatory changes.

Bottom Line

CTS scores higher overall (65/100 vs 41/100). ZEPP offers better value entry with a 48.6% margin of safety. Both earn "Strong Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

CTS Corporation

TECHNOLOGY · ELECTRONIC COMPONENTS · USA

CTS Corporation manufactures and sells sensors, actuators, and connectivity components in North America, Europe, and Asia. The company is headquartered in Lisle, Illinois.

Zepp Health Corp

TECHNOLOGY · CONSUMER ELECTRONICS · China

Zepp Health Corporation, an activity and biometric data-driven company, develops, manufactures and sells smart wearable technology devices in the People's Republic of China. The company is headquartered in Hefei, the People's Republic of China.

Want to dig deeper into these stocks?